We are live on ! Find out more
HHC

Hutchin Hill Capital Portfolio holdings

AUM $359M
1-Year Est. Return 15.77%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+15.77%
3 Year Est. Return
+54.44%
5 Year Est. Return
10 Year Est. Return
AUM
$2.2B
AUM Growth
+$272M
Cap. Flow
+$315M
Cap. Flow %
14.34%
Top 10 Hldgs %
24.21%
Holding
879
New
298
Increased
121
Reduced
135
Closed
291

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$39.5M
2
NCLH icon
Norwegian Cruise Line
NCLH
+$33.1M
3
VTRS icon
Viatris
VTRS
+$30.4M
4
FITB
Fifth Third Bancorp
FITB
+$27.5M
5
HRI icon
Herc Holdings
HRI
+$16.4M

Sector Composition

Rank Sector Weight
1 Financials 26.89%
2 Consumer Discretionary 10.61%
3 Healthcare 10.46%
4 Industrials 10.18%
5 Energy 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INGR icon
276
Ingredion
INGR
$6.58B
$1.34M 0.06%
17,900
-8,800
-33% -$640K
KLIC icon
277
Kulicke & Soffa
KLIC
$4.78B
$1.34M 0.06%
+94,100
New +$1.29M
DY icon
278
Dycom Industries
DY
$12.3B
$1.34M 0.06%
+42,800
New +$1.33M
TBI
279
Trueblue
TBI
$311M
$1.34M 0.06%
+48,543
New +$1.33M
NXGN
280
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$1.34M 0.06%
+83,277
New +$1.32M
GNC
281
DELISTED
GNC Holdings, Inc.
GNC
$1.34M 0.06%
+39,200
New +$1.56M
SXI icon
282
Standex International
SXI
$4.12B
$1.33M 0.06%
+17,900
New +$1.23M
CVC
283
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
$1.33M 0.06%
+75,300
New +$1.29M
WLY icon
284
John Wiley & Sons Class A
WLY
$2.66B
$1.33M 0.06%
21,900
+13,026
+147% +$740K
MANT
285
DELISTED
Mantech International Corp
MANT
$1.32M 0.06%
44,869
+10,669
+31% +$315K
ALB icon
286
Albemarle
ALB
$15.5B
$1.32M 0.06%
+18,400
New +$1.26M
ALR
287
DELISTED
Alere Inc
ALR
$1.31M 0.06%
35,100
+17,300
+97% +$616K
SE
288
DELISTED
Spectra Energy Corp Wi
SE
$1.31M 0.06%
30,900
-7,800
-20% -$312K
BIO icon
289
Bio-Rad Laboratories Class A
BIO
$9.42B
$1.3M 0.06%
+10,900
New +$1.33M
IRF
290
DELISTED
INTL RECTIFIER CORP
IRF
$1.3M 0.06%
+46,600
New +$1.25M
MATX icon
291
Matsons
MATX
$6.18B
$1.3M 0.06%
48,300
+3,600
+8% +$87.7K
GMED icon
292
Globus Medical
GMED
$11.2B
$1.29M 0.06%
54,028
+3,928
+8% +$94.8K
CLW icon
293
Clearwater Paper
CLW
$376M
$1.28M 0.06%
+20,800
New +$1.3M
A icon
294
Agilent Technologies
A
$41.2B
$1.27M 0.06%
+31,036
New +$1.25M
NDZ
295
DELISTED
NORDION INC COM STK (CDA)
NDZ
$1.27M 0.06%
+101,200
New +$1.23M
HI
296
DELISTED
Hillenbrand
HI
$1.27M 0.06%
38,900
+28,700
+281% +$886K
XOM icon
297
ExxonMobil
XOM
$634B
$1.26M 0.06%
+12,500
New +$1.26M
EVRI
298
DELISTED
Everi Holdings
EVRI
$1.26M 0.06%
+141,400
New +$1.12M
THC icon
299
Tenet Healthcare
THC
$21.1B
$1.25M 0.06%
26,700
-45,500
-63% -$2.06M
KFY icon
300
Korn Ferry
KFY
$4.28B
$1.25M 0.06%
42,500
+20,400
+92% +$603K

Similar funds

Hutchin Hill Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Hutchin Hill Capital held 879 positions worth $2.2B, up 14% from $1.92B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Hutchin Hill Capital deployed $315M of net new capital in Q2 2014, opening 298 new positions and adding to 121 existing holdings. Its largest new stake was Williams Companies: 945,000 shares worth $55M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Viatris, an estimated $30.4M trimmed.

  • Hutchin Hill Capital's largest Q2 2014 buy was Williams Companies: 945,000 shares worth $55M.
  • Hutchin Hill Capital added most to Liberty Interactive Corporation Series A Liberty Ventures in Q2 2014, an estimated $28.9M increase.
  • Hutchin Hill Capital's biggest Q2 2014 reduction was Viatris, cutting an estimated $30.4M.
  • Hutchin Hill Capital fully exited Verizon in Q2 2014, selling an estimated $39.5M.
  • Hutchin Hill Capital's ten largest holdings make up 24% of its $2.2B portfolio in Q2 2014.
  • Hutchin Hill Capital opened 298 new positions and closed 291 in Q2 2014.
  • Hutchin Hill Capital's portfolio value rose 14% quarter-over-quarter to $2.2B.

Based on Hutchin Hill Capital's 13F filing for Q2 2014, filed 14 Aug 2014.